HC Wainwright & Co. Reiterates Buy on BrainsWay, Maintains $17 Price Target

Benzinga Newsdesk www.benzinga.com Neutral 90.9%

Neg 0% Neu 90.9% Pos 0%

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates BrainsWay (NASDAQ:BWAY) with a Buy and maintains $17 price target.